Эффективность бактериального лизата как средства предотвращения обострений хобл у пациентов с разной историей предыдущих обострений
И. Н. Челенкова, Наталья Дмитриевна Бунятян, И.Ю. Трофименко · Человек и его здоровье · 2017
The purpose of the study was to estimate the efficiency of oral bacterial lysate OM-85 as a means of preventing COPD exacerbations and related hospitalizations in patients varying in initial frequency of exacerbations of the disease. The retrospective cohort study included 94 in-patients whose previous hospitalization for COPD exacerbations were carried out in the same health facility. 18 follow-ups had received one or more courses of treatment with OM-85 since the previous hospitalization. The efficacy of OM-85 was evaluated in two clusters of patients comparable in volume with different history of previous COPD exacerbations: <2 times a year and ≥ 2 times a year. It was established that OM-85 prolongs the stable course of COPD, and defers the need for next hospitalization for COPD exacerbations almost equally in both clusters of patients.
Cited by 0 works. doi:10.21626/vestnik/2017-1/08 Open-access PDF
Authors
References
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
- Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: A meta-analysis
- Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
- Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review
- Effects of OM‐85 BV in patients with chronic obstructive pulmonary disease: A systematic review and meta‐analysis